Navigation Links
Spectros Corporation Reports 2007 Year-Over-Year Sales Rise 36%

PORTOLA VALLEY, Calif., March 31 /PRNewswire/ -- Spectros Corporation (Portola Valley, CA) reported that 2007 year-over-year sales rose 36%, reflecting growing acceptance of molecular monitoring in the hospital for a broadening array of applications and clinical research areas. The Company's lead product, T-Stat(R), was the first device approved by the FDA as sensitive to ischemia, a condition in which critical organs receive insufficient oxygen. "We are pleased that hospitals are now recognizing the benefits of Ischemia Detection in their clinical practices," notes David Benaron, CEO. Red Herring recently predicted the market for such products in molecular detection, molecular imaging, and treatment guidance, will grow to over $12 billion annually. "We expect significant and continued growth in revenue for the next several years," noted David Benaron, CEO.

Spectros is currently the leader in real-time noninvasive somatic molecular monitoring, such as the T-Stat(R) 303 ischemia detection system. With introduction of probes that monitor in the cranial region, Spectros will compete directly with cerebral oximetry concerns such as Somanetics, CAS Medical, and others. Next generation products for the early diagnosis of breast cancer are entering Phase III trials. (Note: Forward-looking statements are intended as a guide only, and do not constitute an offer for investment nor guarantees of future returns. Some applications described above are for investigation use only, and have not yet been reviewed or approved by the FDA.)

ABOUT THE COMPANY: Spectros Corporation is a venture-supported private corporation that makes advanced molecular sensing and imaging devices that shed light on life-threatening diseases, including ischemia and cancer. Spectros proprietary medical devices embed state-of-the-art biophotonic molecular technologies to enable real-time therapies that speed diagnosis, reduce complications, and lower costs. Spectros is a venture-supported private concern.

SOURCE Spectros Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Fluorescent glass SRMs are new tool for spectroscopy
2. Lentigen Corporation Announces Exclusive Licensing Agreement With Case Western Reserve University to Develop Novel Stem-Cell Therapy for Brain Cancer
3. Oregon Health Care Quality Corporation Receives Important Designation from U.S. Department of Health and Human Services
4. Psychemedics Corporation Authorizes A 250,000 Share Stock Repurchase Program
5. Dr. Linda McAllister Joins Arbor Vita Corporation as Vice President of Diagnostics
6. Webcast Alert: Neogen Corporation Announces 3rd Quarter Results
7. USANAs CEO Myron W. Wentz, Ph.D. Has Been Elected to Serve on Immunosyn Corporations Board of Directors
8. Volcano Corporation Presentation at Cowen Healthcare Conference to be Webcast
9. Somanetics Corporation to Present at Cowen & Company 28th Annual Health Care Conference
10. MannKind Corporation Response to Recent Market Events
11. Alsius Corporation to Host Fourth Quarter and Year-End 2007 Financial Results Conference Call/Webcast on March 13, 2008
Post Your Comments:
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... Pleasant Prairie, WI (PRWEB) , ... June 23, ... ... sciences consultancy focused on quality, regulatory and technical consulting, provides a free ... webinar is presented on July 13, 2016 at 12pm CT at no charge. ...
Breaking Biology Technology:
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:4/14/2016)... , April 14, 2016 ... Malware Detection, today announced the appointment of Eyal ... new role. Goldwerger,s leadership appointment comes at ... heels of the deployment of its platform at several ... biometric technology, which discerns unique cognitive and physiological factors, ...
Breaking Biology News(10 mins):